Renal impact on the role of antihypertensive agents used in the elderly with essential arterial hypertension;Repercusión sobre la función renal de los fármacos antihipertensivos utilizados en ancianos con hipertensión arterial esencial

Hipertension

Volumn 25, Issue 5, 2008, Pages 194-197

  Heras Benito, M ^a   Fernandez Reyes M J ^a   Sanchez R ^a   Guerrero, M T ^a   Prado, F ^a   Alvarez Ude F ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

Antihypertensive; Diuretics; Elderly; Hypertension; Renal function

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; CREATININE BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION; HUMAN; KIDNEY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROTEINURIA; SIDE EFFECT;

EID: 56649102022     PISSN: 02128241     EISSN: 15782115     Source Type: Journal    
DOI: 10.1016/s0212-8241(08)75978-4     Document Type: Article

References (17)

1. Martín-Baranera M, Sánchez Ferrín P, Armario P. Geriatric HTA Study Group: prevalence of hipertension in elderly long-term care residents in Spain. The Geriatric HTA Study. Med Clin (Barc). 2006;127(18):681-7.
2. Plouin PF, Rossignol P, Bobrie G. Hypertension in elderly. Bull Acad Natl Med. 2006;190(4-5):793-806.
3. Wenzel RR. Renal protection in hypertensive patients: selection of antihypertensive therapy. Drugs. 2005;65(S2):29-39.
4. Nash DT. Systolic hypertension. Geriatrics. 2006;61(12):22-8.
5. Leonetti G, Cuspidi C, Facchini M. Antihypertensive therapy in the elderly: results of large trials. Ital Heart J. 2001;11Suppl2:1161-9.
6. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
7. Levey AS, Greene T, Kusek JW, Beck GJ. Simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:828(A).
8. Giles TD, Berk BC, Black HR, Cohn JN, Kostis JB, Izzo JL, et al. Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich). 2005;7:505-12.
9. Atkins RC. The epidemiology of chronic kidney disease. Kidney Int. 2005;94 Suppl:S14-8.
10. Eknoyan G. On epidemic cardiovascular disease in patients with chronic renal disease and progresive renal failure: a first step to improve the outcomes. Am J Kidney Dis. 1998;32:S1-4.
11. Kidney Disease Outcome Quality Inititative: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S76-92.
12. Cinza Sanjurjo S, Cabarcos Ortiz de Barrón A, Nieto Pol E, Lorenzo Zúñiga V. Control of hipertension in elderly patients admitted in internal medicine. An Med Interna. 2006;23(8):369-73.
13. Kaplan NM. Tratamiento de la hipertension: farmacoterapia. En: Kaplan NM, editor. Hipertensión clínica. Ed. Waverly hispánica, S.A.; 2003. p. 237-338.
14. Lindholm LH, Carlberg B, Samuelsson O. Should β-blockers remain first choice in the treatment of primary hypertension? A metaanalysis. Lancet. 2005,366:1545-53.
15. Stokes GS. Treatment of isolated systolic hypertension. Curr Hypertens Rep. 2006;8(5):377-83.
16. Rose BD. Diuretics. Kidney Int. 1991;39(2):336-52.
17. Lottermoser K, Hertfelder HJ, Vetter H, Düsing R. Fibrinolytic function in diuretic-induced volume depletion. Am J Hypertens. 2000;13:359-63.